These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 15569121)

  • 1. Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial.
    Nista EC; Candelli M; Cremonini F; Cazzato IA; Zocco MA; Franceschi F; Cammarota G; Gasbarrini G; Gasbarrini A
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1181-8. PubMed ID: 15569121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-day triple therapy with rabeprazole, amoxicillin and clarithromycin in the eradication of Helicobacter pylori in patients with peptic ulcer disease--A pilot study.
    Lüth S; Teyssen S; Kölbel CB; Singer MV
    Z Gastroenterol; 2001 Apr; 39(4):279-81, 284-5. PubMed ID: 11367976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
    Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J
    Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High rate of Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a prospective controlled study.
    Zullo A; Gatta L; De Francesco V; Hassan C; Ricci C; Bernabucci V; Cavina M; Ierardi E; Morini S; Vaira D
    Aliment Pharmacol Ther; 2005 Jun; 21(12):1419-24. PubMed ID: 15948808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: a prospective randomized placebo-controlled double-blind study.
    Cindoruk M; Erkan G; Karakan T; Dursun A; Unal S
    Helicobacter; 2007 Aug; 12(4):309-16. PubMed ID: 17669103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amoxycillin, clarithromycin and either sucralfate or pantoprazole for eradication of Helicobacter pylori in duodenal ulcer (a randomized controlled trial).
    Vcev A; Vceva A; Kurbel S; Takac B; Stimac D; Ivandić A; Ostojić R; Barbir A; Hovat D; Mihaljević S
    Wien Klin Wochenschr; 2001 Dec; 113(23-24):939-41. PubMed ID: 11802510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seven-day therapy for Helicobacter pylori in the United States.
    Vakil N; Lanza F; Schwartz H; Barth J
    Aliment Pharmacol Ther; 2004 Jul; 20(1):99-107. PubMed ID: 15225176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual therapy using a double dose of lansoprazole with amoxicillin versus triple therapy using a double dose of lansoprazole, amoxicillin, and clarithromycin to eradicate Helicobacter pylori infection: results of a prospective randomized open study.
    Lamouliatte H; Cayla R; Zerbib F; Forestier S; de Mascarel A; Joubert-Collin M; Mégraud F
    Am J Gastroenterol; 1998 Sep; 93(9):1531-4. PubMed ID: 9732938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration.
    Stack WA; Knifton A; Thirlwell D; Cockayne A; Jenkins D; Hawkey CJ; Atherton JC
    Am J Gastroenterol; 1998 Oct; 93(10):1909-13. PubMed ID: 9772054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and pharmaceutical cost of sequential treatment for Helicobacter pylori in patients with non-ulcer dyspepsia.
    De Francesco V; Della Valle N; Stoppino V; Amoruso A; Muscatiello N; Panella C; Ierardi E
    Aliment Pharmacol Ther; 2004 May; 19(9):993-8. PubMed ID: 15113366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twice-daily, 10-day triple therapy with omeprazole, amoxicillin, and clarithromycin for Helicobacter pylori eradication in duodenal ulcer disease: results of three multicenter, double-blind, United States trials.
    Laine L; Suchower L; Frantz J; Connors A; Neil G
    Am J Gastroenterol; 1998 Nov; 93(11):2106-12. PubMed ID: 9820381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study.
    Cremonini F; Di Caro S; Covino M; Armuzzi A; Gabrielli M; Santarelli L; Nista EC; Cammarota G; Gasbarrini G; Gasbarrini A
    Am J Gastroenterol; 2002 Nov; 97(11):2744-9. PubMed ID: 12425542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance?
    Lerang F; Moum B; Haug JB; Tolås P; Breder O; Aubert E; Høie O; Søberg T; Flaaten B; Farup P; Berge T
    Am J Gastroenterol; 1997 Feb; 92(2):248-53. PubMed ID: 9040200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised clinical trial: a comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naïve patients.
    Park HG; Jung MK; Jung JT; Kwon JG; Kim EY; Seo HE; Lee JH; Yang CH; Kim ES; Cho KB; Park KS; Lee SH; Kim KO; Jeon SW
    Aliment Pharmacol Ther; 2012 Jan; 35(1):56-65. PubMed ID: 22066530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seven versus ten days of rabeprazole triple therapy for Helicobacter pylori eradication: a multicenter randomized trial.
    Calvet X; Ducons J; Bujanda L; Bory F; Montserrat A; Gisbert JP;
    Am J Gastroenterol; 2005 Aug; 100(8):1696-701. PubMed ID: 16086704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori.
    Uygun A; Kadayifci A; Safali M; Ilgan S; Bagci S
    J Dig Dis; 2007 Nov; 8(4):211-5. PubMed ID: 17970879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of probiotics on PPI-triple therapy for Helicobacter pylori eradication.
    Kim MN; Kim N; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Kim JS; Jung HC; Song IS
    Helicobacter; 2008 Aug; 13(4):261-8. PubMed ID: 18665934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the efficacy of 1-day high-dose quadruple therapy versus 7-day triple therapy for treatment of Helicobacter pylori infection.
    Zheng Q; Pan Y; Zhang L; Xiao SD
    Chin J Dig Dis; 2005; 6(4):202-5. PubMed ID: 16246231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential therapy versus standard triple drug therapy for eradication of Helicobacter pylori in patients with perforated duodenal ulcer following simple closure.
    Valooran GJ; Kate V; Jagdish S; Basu D
    Scand J Gastroenterol; 2011 Sep; 46(9):1045-50. PubMed ID: 21627398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lafutidine versus lansoprazole in combination with clarithromycin and amoxicillin for one versus two weeks for Helicobacter pylori eradication in Korea.
    Kim N; Park SH; Seo GS; Lee SW; Kim JW; Lee KJ; Shin WC; Kim TN; Park MI; Park JJ; Hong SJ; Shim KN; Kim SW; Shin YW; Chang YW; Chun HJ; Lee OJ; Jeon WJ; Park CG; Cho CM; Park CH; Won SY; Lee GH; Park KS; Shin JE; Kim HU; Park JY; Chae HS; Song GA; Kim JG; Yoon BC; Seol S; Jung HC; Chung IS
    Helicobacter; 2008 Dec; 13(6):542-9. PubMed ID: 19166420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.